Green Tea Extract for Endometriosis Treatment
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Endometriosis
- Type
- Interventional
- Phase
- Phase 2
- Design
- Allocation: RandomizedIntervention Model: Parallel AssignmentMasking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)Primary Purpose: Treatment
Participation Requirements
- Age
- Between 18 years and 40 years
- Gender
- Only males
Description
Women with endometrioma will be randomised into either the experimental group or the placebo comparator group in a 1:1 ratio. The subjects will be given SUNPHENON EGCg or placebo for 3 months prior to their planned surgery.
Women with endometrioma will be randomised into either the experimental group or the placebo comparator group in a 1:1 ratio. The subjects will be given SUNPHENON EGCg or placebo for 3 months prior to their planned surgery.
Tracking Information
- NCT #
- NCT02832271
- Collaborators
- Chinese Academy of Medical Sciences
- Sun Yat-sen University
- Guangdong Provincial Hospital of Traditional Chinese Medicine
- Jiangxi University of Traditional Chinese Medicine
- Investigators
- Principal Investigator: Ronald Wang, MD PhD Chinese University of Hong Kong
Get Well Soon